美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
TRIJARDY XR	212614	001	NDA	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	5MG;2.5MG;1GM	Yes	No	2020/01/27	2020/01/27	BOEHRINGER INGELHEIM	Prescription
TRIJARDY XR	212614	002	NDA	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	10MG;5MG;1GM	Yes	No	2020/01/27	2020/01/27	BOEHRINGER INGELHEIM	Prescription
TRIJARDY XR	212614	003	NDA	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	12.5MG;2.5MG;1GM	Yes	No	2020/01/27	2020/01/27	BOEHRINGER INGELHEIM	Prescription
TRIJARDY XR	212614	004	NDA	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	25MG;5MG;1GM	Yes	Yes	2020/01/27	2020/01/27	BOEHRINGER INGELHEIM	Prescription